Data Analysis in Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Data Analysis in Clinical Trials in Brazil

Data Analysis in Clinical Trials in Brazil – Advantages of Clinical Trials

Data analysis has emerged as a game-changer in the realm of clinical trials, transforming the landscape of medical research and healthcare worldwide. In Brazil, a country at the forefront of clinical trials and medical advancements, data analysis is playing a pivotal role in driving improvements in healthcare outcomes, patient safety, and the development of innovative treatments.

In this blog post, we will delve into the significance of data analysis in clinical trials specifically within the context of Brazil, and how it is shaping the future of healthcare in the country.

Optimizing Trial Design and Planning:

Data analysis serves as a cornerstone during the initial stages of clinical trial design and planning. Brazilian researchers rely on comprehensive data analysis to examine historical clinical trial data, population demographics, and epidemiological information.

By harnessing this data, researchers can construct robust study protocols, identify relevant patient populations, determine optimal sample sizes, and estimate statistical power. This ensures that clinical trials are methodologically sound, cost-effective, and ethically viable, allowing for the efficient allocation of resources.

Improving Patient Recruitment and Retention:

Patient recruitment and retention are critical challenges in clinical trials. Data analysis plays a pivotal role in overcoming these obstacles in Brazil. By analyzing demographic and clinical characteristics, Brazilian researchers can identify suitable patient populations, ensuring diversity and representation within the trials.

Additionally, data analysis can predict patient dropout rates, enabling researchers to implement strategies that enhance patient retention throughout the trial, thereby increasing the reliability and validity of the study results.

Real-time Monitoring and Safety:

Data analysis is instrumental in real-time monitoring of patient safety during clinical trials. Brazilian researchers employ advanced analytical techniques to analyze patient data collected throughout the trials. By monitoring adverse events, laboratory values, and other safety indicators in real-time, researchers can swiftly identify potential risks and intervene when necessary. This ensures the well-being of trial participants and helps maintain the integrity of the trial data, promoting patient safety and reliable results.

Data Analysis in Clinical Trials in Brazil

Data Analysis in Clinical Trials in Brazil

Data Analysis in Clinical Trials in Brazil

Efficient Data Management:

The sheer volume of data generated by large-scale clinical trials can be overwhelming to manage and analyze. Data analysis techniques streamline data management processes in Brazilian clinical trials.

From data cleaning and standardization to data integration and quality control, advanced analytical tools ensure accurate, reliable, and readily available data for analysis. This empowers researchers to derive meaningful insights, make informed decisions, and produce robust study outcomes.

Statistical Analysis and Interpretation:

Data analysis techniques, such as statistical modeling and machine learning, unlock valuable insights from clinical trial data for Brazilian researchers. By applying appropriate statistical tests, researchers can evaluate treatment efficacy, assess safety profiles, and uncover potential correlations or associations.

These insights aid in data interpretation and support evidence-based decision-making in the development of novel therapies and treatments, driving advancements in Brazilian healthcare.

Post-trial Analysis and Reporting:

Data analysis remains indispensable even after the completion of a clinical trial. In Brazil, researchers analyze trial data to summarize study findings, evaluate overall trial success, and generate reports for regulatory submissions.

Moreover, post-trial analysis enables the identification of areas for improvement in future trials, contributing to the continuous enhancement of the clinical research landscape in Brazil.


Data analysis is revolutionizing the field of clinical trials in Brazil, empowering researchers and healthcare professionals to make informed decisions, enhance patient outcomes, and drive advancements in healthcare. By harnessing the power of data analysis, clinical trials in Brazil can optimize trial design, improve patient recruitment and retention, ensure patient safety, streamline data management, and extract meaningful insights.

As Brazil continues to foster an environment conducive to medical research, the integration of data analysis will undoubtedly play a pivotal role in shaping the future of clinical trials and revolutionizing healthcare in the country.

Data Analysis in Clinical Trials in Brazil
Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Data Analysis in Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Data Analysis in Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Data Analysis in Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Data Analysis in Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Data Analysis in Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Data Analysis in Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Data Analysis in Clinical Trials in Brazil

The Cohortias Team

Data Analysis in Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Data Analysis in Clinical Trials in Brazil

Network & Partnerships